On May 15, 2025, breath sample collection began at the IRCCS “S. De Bellis” in Castellana Grotte, a hospital specialized in gastroenterology and one of the most prominent healthcare institutions in Puglia and across Italy. This date marks a significant milestone for the Endoscope project, […]
The year 2024 marks a crucial milestone for Mistral, with the launch of major clinical trials in collaboration with centers of excellence throughout Italy. Mistral is a certified medical device (CEE 93/42) that captures volatile organic compounds (VOCs) in human breath with a simple […]
Predict is participating, alongside the University of Bari and the University of Salento, in the Endoscope project, funded under the “D3-4Health” cascade calls promoted by Sapienza University of Rome. D3-4Health (Digital Driven Diagnostics, Prognostics and Therapeutics for Sustainable Healthcare) is an initiative involving 28 […]
Palmisani J.1*, Di Gilio A.1, Pizzillo V.1, Tosoni E.2, de Gennaro G.1, Perbellini L.3, Santo A.2 1 Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, 70125 Bari, Italy 2 Lung Unit, P. Pederzoli Hospital, 37019 Peschiera del Garda, Verona, Italy 3 University of Verona, 37129 Verona, Italy * presenting author RATIONALE OF THE STUDY: Lung cancer (LC) is one of the most aggressive tumors and the leading cause of cancer-related […]
Martina Pecoraro: Rome / ItalvAuthor Block: M. Pecoraro, S. Novelli, E. Messina, L. Laschena, C. Catalano, V. Panebianco; Rome/ITPurpose: This study aimed to deliver novel, cost-effective, evidence-based, non-invasive predictive risk-adapted diagnostic pathways for faster, earlier, more precise, accessible, and affordable detection and screening of prostate cancer. Methods or Background: A prospective single-centre cohort study, enrolling […]
Lo Sasso A., Bellantuono L., Facchini L., Amato E., Porcelli F., Frascella P., Bellotti R. Prostate cancer stands as the most prevalent cancer among males in Italy, comprising 18.5% of all male cancer diagnoses. Nearly a quarter of men receive a prostate cancer diagnosis between ages 50 and 60. Detecting this cancer early could potentially […]
Catino A.1, Di Gilio A.2,3, Palmisani J.2,3, Nisi M.R. 2, Varesano N.1, Galetta D.1, de Gennaro G.2,3 1 Thoracic Oncology Unit, Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy 2 Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, Bari, Italy 3 Apulian Regional Centre for the Breath Analysis, Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy Introduction Malignant Pleural Mesothelioma (MPM) is a rare neoplasm cancer with still a poor prognosis and mainly […]
Manetta Rosa, Daffinà Julia, Martinese Andrea, Gazzerro Alessia, De Simone Stefano, Ciccone Vincenzo, Masciocchi Carlo, Di Cesare Ernesto Objective: The primary objective of this study is to identify and characterize a pattern of volatile compounds capable of discriminating, through appropriate statistical treatment, patients with prostate cancer (PCa) from healthy reference individuals. Materials and Methods: This prospective pilot trial was conducted in the RadiodiagnosticsDepartment […]
A. Lo Sasso, L. Bellantuono, R. Manetta, A. Gazzerro, R. Di Filippo, F. Porcelli, L. Facchini, P. Frascella and R. Bellotti Breath analysis is emerging as a promising screening technique. Analysis of volatile organic compounds by artificial intelligence can lead to an early warning bell by noninvasive screening. In this work, we analyze volatile organic […]
Manetta Rosa, Daffinà Julia, Martinese Andrea, Gazzerro Alessia, De Simone Stefano, Ciccone Vincenzo, Masciocchi Carlo, Di Cesare Ernesto Objective: The primary objective of this study is to identify and characterize a pattern of volatile compounds capable of discriminating, through appropriate statistical treatment, patients with prostate cancer (PCa) from healthy reference individuals. Materials and Methods: This prospective pilot trial was conducted in the RadiodiagnosticsDepartment […]
